Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Feb 1;139(2):355-66.
doi: 10.1084/jem.139.2.355.

Properdin factor D: characterization of its active site and isolation of the precursor form

Properdin factor D: characterization of its active site and isolation of the precursor form

D T Fearon et al. J Exp Med. .

Abstract

The activity of properdin factor D was measured by the generation of the hemolytically active cellular intermediate, EAC43B(D), bearing the C3b-dependent alternate pathway C3 convertase. Treatment of factor D with DFP prevented formation of EAC43B(D); thus, a serine esterase is essential for the generation of the alternate pathway C3 convertase, a situation analogous to the role of C1 in the formation of the classical C3 convertase, C42. The definition of factor D as a serine esterase prompted a search for its proenzyme form, and resulted in the chromatographic isolation from plasma of a single peak of trypsin-inducible factor D activity, distinct from activated factor D. Analytical gel filtration indicated an apparent mol wt of 25,000. This protein from which trypsin elaborated factor D activity, as assessed by the formation of EAC43B(D), the generation of the CoVF-dependent C3 convertase, and the cleavage of factor B in the presence of C3b, was designated "precursor factor D." The DFP resistance of precursor factor D, and the susceptibility of its trypsin-activated form to inactivation by DFP is analogous to the behavior of other plasma serine esterases, including C1.

PubMed Disclaimer

References

    1. Immunochemistry. 1966 Jan;3(1):11-20 - PubMed
    1. J Exp Med. 1965 Aug 1;122:277-98 - PubMed
    1. J Immunol. 1967 Aug;99(2):263-8 - PubMed
    1. J Immunol. 1967 Dec;99(6):1162-72 - PubMed
    1. J Immunol. 1968 Jan;100(1):142-58 - PubMed